GlaxoSmithKline plc (LON:GSK): Has Recent Earnings Growth Beaten Long-Term Trend?
https://simplywall.st/stocks/gb/pharmaceuticals-biotech/lse-gsk/glaxosmithkline-shares/news/glaxosmithkline-plc-longsk-has-recent-earnings-growth-beaten-long-term-trend/
59.17%
Should You Buy GlaxoSmithKline plc (LON:GSK) Now?
https://simplywall.st/stocks/gb/pharmaceuticals-biotech/lse-gsk/glaxosmithkline-shares/news/should-you-buy-glaxosmithkline-plc-longsk-now/
58.12%
GlaxoSmithKline (LON:GSK) PT Set at GBX 1475 by Jefferies Group
https://ledgergazette.com/2018/03/06/glaxosmithkline-gsk-given-a-gbx-1475-price-target-by-jefferies-group-analysts.html
51.66%
GlaxoSmithKline PLC (LON:GSK) Rating Reaffirmed by Analysts at Shore Capital Today
http://newburghgazette.com/2018/03/04/glaxosmithkline-plc-lon-gsk-rating-reaffirmed-by-analysts/
50.0%
4 attractive dividend shares? SSE PLC, Centrica PLC, BHP Billiton plc and GlaxoSmithKline plc
https://investomania.co.uk/2018/03/4-attractive-dividend-shares-sse-plc-centrica-plc-bhp-billiton-plc-glaxosmithkline-plc/
58.33%
GlaxoSmithKline (LON:GSK) PT Set at GBX 1320 by JPMorgan Chase & Co.
https://stocknewstimes.com/2018/02/26/glaxosmithkline-gsk-given-a-gbx-1320-price-target-by-jpmorgan-chase-co-analysts.html
50.5%
GlaxoSmithKline's (LON:GSK) Overweight Rating Reiterated at Barclays
https://ledgergazette.com/2018/02/25/glaxosmithkline-gsk-earns-overweight-rating-from-barclays.html
47.43%
Kepler Capital Markets Has Just Given Glaxosmithkline (LON:GSK) a Higher Rating. The TP is GBX 1360.00
https://friscofastball.com/kepler-capital-markets-has-just-given-glaxosmithkline-longsk-a-higher-rating-the-tp-is-gbx-1360-00/
51.03%
